Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University Licensed Patents Expected to Provide Freedom to Operate and Exclusivity for Emricasan Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases ...